Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Jabak Visited the Mais al-Jabal, Tebnine and Bint Jbeil Hospitals: I will Try to Support the Disadvantaged Areas with the Possible Means

 
Tebnine- Minister of Public Health Dr. Jamil Jabak visited this afternoon Tebnine Hospital as part of his tours of governmental hospitals in Marjayoun and Bint Jbeil districts. Jabak was received by MPs Ayoub Hmayyed, Hasan Fadlallah and Ali Bazzi, the chairman of the board of directors of the hospital Dr. Mohamad Hamadeh, the administrative body as well as physicians, Hezbollah official Cheikh Fouad Hanjoul and figures.
 
Jabak visited the hospital’s facilities and heard a briefing by Hamadeh of the equipment and the operations undertaken at the hospital and the large number of patients admitted to the hospital, coming from different regions and villages.

Jabak vowed to exert all possible efforts to provide assistance to the disadvantaged areas within the possible means in collaboration with the parliament and the Health committee.

“I promise to raise the financial ceiling of the governmental hospitals. Our top priority is to improve the quality of services provided by the governmental hospitals and rehabilitate them to admit patients all the month, in particular the uninsured ones,” Jabak added.
Jabak considered also that the salary scale law should apply to the employees and workers of the hospitals.
 
In a statement, Hmayed praised the effective role played by the Minister of Public Health.
 
Jabak and the MPs then visited Bint Jbeil Governmental hospital, where he was received by the chairman of the board of directors, Dr. Toufic Faraj and other figures.
 
“We are committed to provide a pioneering experience in the health care field. We deserve to have the best hospitals. Bint Jbeil Governmental hospital has the best equipment, so why should we transfer the patients to other hospitals or take them to hospitals in Sidon and Beirut?” Fadlallah stated.
 
Jabak visited later Mays al-Jabal Governmental Hospital with MPs Ali Fayyad and Kasem Hachem. He toured its facilities and departments and was informed on its needs in terms of the provision of medical services.
    ...
    10
    ...
ATC Name B/G Ingredients Dosage Form Price
J07BC02 HAVRIX JUNIOR 720 B Hepatitis A, inactivated, whole virus - 720 ELISA units/0.5ml 720 ELISA units/0.5ml Injectable suspension 1,491,665 L.L
N02CD01 AIMOVIG BioTech Erenumab - 70mg/ml 70mg/ml Injectable solution 35,423,371 L.L
L01EA02 SPRYCEL B Dasatinib - 70mg 70mg Tablet 212,274,841 L.L
L01EA02 APO-DASATINIB G Dasatinib - 70mg 70mg Tablet 71,323,688 L.L
L01EA02 DALEUBIN G Dasatinib - 70mg 70mg Tablet, film coated 102,415,923 L.L
L01EA02 DASATINIB NEAPOLIS G Dasatinib - 70mg 70mg Tablet, film coated 127,364,905 L.L
L01EA02 ELPIDA G Dasatinib - 70mg 70mg Tablet, film coated 127,364,905 L.L
L01EA02 DASATINIB NEAPOLIS G Dasatinib - 70mg 70mg Tablet, film coated L.L
J02AX04 CANCIDAS B Caspofungin (acetate) - 70mg 70mg Injectable concentrated powder for solution 31,611,335 L.L
J02AX04 CANDIGARD G Caspofungin (acetate) - 70mg 70mg Injectable powder for concentrate for solution 22,127,179 L.L
J02AX04 CASPOFUNGINE STRAGEN G Caspofungin (acetate) - 70mg 70mg Injectable concentrated powder for solution 22,928,852 L.L
M05BA04 FOSAMAX 70MG ONCE WEEKLY B Alendronate - 70mg 70mg Tablet 1,988,887 L.L
M05BA04 APO-ALENDRONATE G Alendronate (monosodium trihydrate) - 70mg 70mg Tablet 981,005 L.L
M05BA04 MARVIL 70 G Alendronate (monosodium trihydrate) - 70mg 70mg Tablet, coated 1,173,175 L.L
M05BA04 OREK G Alendronate - 70mg 70mg Tablet, coated 2,404,838 L.L
M05BA04 OSTEOMED G Alendronic acid (sodium alendronate) - 70mg 70mg Tablet, scored 950,929 L.L
M05BA04 STRONDEX 70 G Alendronate sodium - 70mg 70mg Tablet 1,305,447 L.L
M05BA04 BINOSTO B Alendronate sodium - 70mg 70mg Tablet, effervescent 1,709,368 L.L
R05DB21 PRIVITUSS G L-Cloperastine - 708mg/100ml 708mg/100ml Suspension 801,186 L.L
N05AX13 BYANNLI B Paliperidone - 700mg 700mg Injectable suspension, prolonged release 96,913,176 L.L
S01BA01 OZURDEX B Dexamethasone - 700mcg 700mcg Implant 80,696,540 L.L
S01BA01 OZURDEX B Dexamethasone - 700mcg 700mcg Implant 80,696,540 L.L
N01BB09 ROPIVACAINA MOLTENI G Ropivacaine HCl - 75mg/10ml 7.5mg/ml Injectable solution 2,332,911 L.L
N01BB09 ROPIVACAINE B. BRAUN G Ropivacaine HCl - 75mg/10ml 7.5mg/ml Injectable solution 4,831,114 L.L
G02CX01 TRACTOCILE B Atosiban acetate - 7.5mg/ml 7.5mg/ml Injectable solution 2,592,272 L.L
G02CX01 TRACTOCILE B Atosiban acetate - 7.5mg/ml 7.5mg/ml Injectable solution 8,282,804 L.L
A10BX16 MOUNJARO KWIKPEN B Tirzepatide - 7.5mg/dose 7.5mg/dose Injectable solution 39,601,065 L.L
R05DB13 TUSSIN G Butamirate citrate - 7.5mg/5ml 7.5mg/5ml Syrup, sugar free 296,925 L.L
R05DB13 TUSSIN G Butamirate citrate - 7.5mg/5ml 7.5mg/5ml Syrup, sugar free 154,862 L.L
B01AX05 ARIXTRA B Fondaparinux sodium - 7.5mg/0.6ml 7.5mg/0.6ml Injectable solution 12,004,668 L.L
    ...
    10
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025